Pfizer looks to test $50, and possibly the gap around 46~ if things get really ugly. Omicron is looking really promising as granting significant immunity after infection, which should reduce demand for further vaccinations. These vaccines companies have YEARS of covid priced into their stocks... Short side is getting a bit long in the tooth for new entries,...
While we need another week~ to confirm, many leading scientists are pointing to death rates anywhere from 30% to 90% lower with Omicron. Yes, it's still problematic but there's hope for the first time in a long time. What happens is Omicron becomes the dominant variant and the majority of people have minimal symptoms?
We could see a DRASTIC repricing in some of...
Hello everybody,
As far as I understand, we are in the wave 3 of the wave 5. We surely can see some correctrion up to 275$ in the 4th wave.
It would be nice top hear your ideas and views about this interpretation of Elliott Wave Principle on the example of Moderna stock
MRNA going according to plan from my earlier posts. I can't update with charts anymore, for some reason? So I am posting again. Re-iterating targets in the 170-180 range. $230 is the Line in the Sand for bearish continuation. took off a few of my puts today.
Massively bearish setup on MRNA. Whether we get one more deadcat, I do not know, but this thing is going to 170/180 area and could be as soon as next week. $125 is my final target. The amount of downside risk in MRNA is absolutely staggering. This is basically a $50-70 stock without the covid premium.
50sma has been an important moving average for this ETF.
We see 3 consecutive tests of the 50sma as resistance and a bounce lower.
As we see lower highs and lower lows, the bearish trend is confirmed.
I expect we fail again and test the blue line ($144.5).
Hello Traders,
welcome to this free and educational analysis.
I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities.
If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below.
If you enjoyed this analysis, I would definitely...
The new covid strain "Omicorn" is spreading quickly all over the world.
The obvious play for covid is investing in vaccines.
PFE all time high is $61, currently its at $58.
Where MRNA all time high is $500, currently its $248. Thats 50% discount from ATH.
Technical:
There is a clear strong support trend line that we're bouncing off.
BlueWave is setting up to...
Description
Today saw MRNA performing a high-volume bounce from the 224 support line which initiated the start of what appears to be a rough Descending Triangle.
I am bearish on MRNA for the longer term, but expect this upward move to continue throughout the week, along with the rest of the indexes that have seen a strong bounce today.
At the least, I am...
NEXCF has just broken its long downtrend line which is usually due to some fundamental change in the company and trajectory of cash flow. The company has rebranded more into an AR 3D marketing company. They still have their digital edtech app and online conferencing but the reposition was a wise one considering the pandemic is coming to an end and many employees...
MRNA targeting $125 and it could happen FAST. Massive insider selling the past month and evidence is building that Omicron will leave the infected with a robust immunity. The case for vaccines is eroding by the day and hard to argue that the current orders for MRNA are not priced in. Very dangerous to be long PFE and MRNA right now
Omnicron is on the rise and the travel season is going to further increase the number of cases in US. More and more people are running for booster shots as well. The stock was hammered last week and is close to oversold on longer timeframes. Thursday saw a nice reversal from 238 for a potential double bottom on 30 mins.
TRADE IDEA:
260C 12/31 on break of $253
TP:...
Share prices are now out of the bearish channel and have breached a major resistance line at 2784.84 and the 200 MA line in M30. Share prices are now out at open waters and could navigate its way back up if it holds above 278.84. We have resistance around 298 and 310
Arcturus Therapeutics Holdings Inc. $ARCT is set to be EBITDA positive in 2022 with a massive change in its revenue from 24.05M in 2021 to 326.44M in 2022. This is 12.57x increase in revenue. These numbers are estimates, but even with a large error margin we should see a drastic change in the price. Moreover, the decline from ATH was 80% and the price has been in...
I've been waiting for MRNA to have some stabilization during it's pullbacks -- now is the time in my opinion. For pharmaceutical companies the vaccines have been their "bread and butter" and they'll ensure they continue to innovate through a variety of new accommodations for people around the world pertaining to Covid, HIV, and anything else they can acquire...
Moderna is getting hot with Omicron Covid variant.
It almost has no investment attractiveness from current levels, but it has potential for making some sort of reverse pattern (so we will probably see some upward movement in short-term)
You can open potential long-term short positions from fibo levels (red lines)
Dump it!
technicals showing a possible DTL in the next coming trading sessions.. has been parabolic the past few days prior now and ever since we've been long ;)
